Table 2

Reference and prototype GBS strains without detectable expression of any of the antigens Z1, Z2, and R3

StrainMLSTSerotype
A909 (NCTC 11078)7Ia/Cα, Cβ
515 (BAA-1177)23Ia/Alp1
090R (NCTC 9993)25Ia/Alp1
70339 (NCTC 129077Ia/Cβ, R4/rib
335 (NCTC 12906)23Ia/Alp1
H36B (NCTC 8187)6Ib/Cα, Cβ
18RS21 (NCTC 11079)19II/R4/rib
08-60a19II/R4/rib
NEM316 (ATCC 12403)23III/Alp2
COH1 (BAA-1176)17III/R4/rib
65604a19III/R4/rib
BM110b17III/R4/rib
15626/81a,c10IV/Cα, Cβ
3139 (ATCC 49446)2IV/Alp1
2603 (BAA-611)110V/R4/rib
CJB111 (BAA-23)1V/Alp3
NT6 (CCUG 29785)14VII/Alp1
7271 (Jelinkova)1VII/Alp3
JM9(Jelinkova)1VIII/Alp3
161757a,c1V/Alp3
  • a Prototype strains of the Department of Medical Microbiology, St. Olav's University Hospital, Trondheim, Norway.

  • b Received from G. Lindahl, Lund, Sweden.

  • c Negative-control strains.